In the wake of the new code of conduct for direct-to-consumer advertising issued by the Pharmaceutical Research and Manufacturers of America, Pfizer this morning formally announced its own internal
changes to DTC advertising that include more risk information in ads and a reinforcement of the doctor-patient relationship.
Read the whole story at Adage.com, August 11, 2005 »